Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma

Overview of attention for article published in Clinical Sarcoma Research, August 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 106)
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 18 X posts from 18 X users, with an upper bound of 24,973 followers.

RT @samdoc_mamc: Sharing our report of good outcome with #trabectedin in multiply relapsed #mesenchymal #chondrosarcoma https://t.co/FRytrt…

RT @samdoc_mamc: Sharing our report of good outcome with #trabectedin in multiply relapsed #mesenchymal #chondrosarcoma https://t.co/FRytrt…

RT @samdoc_mamc: Sharing our report of good outcome with #trabectedin in multiply relapsed #mesenchymal #chondrosarcoma https://t.co/FRytrt…

RT @samdoc_mamc: Sharing our report of good outcome with #trabectedin in multiply relapsed #mesenchymal #chondrosarcoma https://t.co/FRytrt…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.